Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05132075
Title Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer (KontRASt-02)
Acronym KontRASt-02
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | SVN | ROU | LBN | ITA | ISL | HUN | GRC | FIN | ESP | CAN | AUS | ARG

Facility Status City State Zip Country Details
Valley Medical Center Research Valley Professional Center Bld Renton Washington 98055 United States Details
Valley Medical Center Research Renton Washington 98055 United States Details
Novartis Investigative Site Caba Buenos Aires C1414DRK Argentina Details
Novartis Investigative Site Pilar Buenos Aires B1629AHJ Argentina Details
Novartis Investigative Site Auchenflower Queensland 4066 Australia Details
Novartis Investigative Site South Brisbane Queensland 4101 Australia Details
Novartis Investigative Site Montreal Quebec H4A 3J1 Canada Details
Novartis Investigative Site Sherbrooke Quebec J1H 5N4 Canada Details
Novartis Investigative Site Fuzhou Fujian 350014 China Details
Novartis Investigative Site Guangzhou Guangdong 510080 China Details
Novartis Investigative Site Harbin Heilongjiang 150081 China Details
Novartis Investigative Site Changsha Hunan 410013 China Details
Novartis Investigative Site Shengyang Liaoning 110042 China Details
Novartis Investigative Site Jinan Shandong 250117 China Details
Novartis Investigative Site Shenyang Shengyang 110041 China Details
Novartis Investigative Site Hangzhou Zhe Jiang 310003 China Details
Novartis Investigative Site Hangzhou Zhejiang 310003 China Details
Novartis Investigative Site Beijing 100730 China Details
Novartis Investigative Site Chongqing 400042 China Details
Novartis Investigative Site Medellin Antioquia 050001 Colombia Details
Novartis Investigative Site Turku FI-20521 Finland Details
Novartis Investigative Site Athens GR 115 27 Greece Details
Novartis Investigative Site Athens 11526 Greece Details
Novartis Investigative Site Heraklion Crete 711 10 Greece Details
Novartis Investigative Site Heraklion Crete 71110 Greece Details
Novartis Investigative Site Kowloon Hong Kong Details
Novartis Investigative Site Shatin New Territories Hong Kong Details
Novartis Investigative Site Shatin HONGKONG Hong Kong Details
Novartis Investigative Site Budapest 1121 Hungary Details
Novartis Investigative Site Reykjavik IS-101 Iceland Details
Novartis Investigative Site Jaipur Rajasthan 302019 India Details
Novartis Investigative Site Delhi 110 085 India Details
Novartis Investigative Site Lucca LU 55100 Italy Details
Novartis Investigative Site Aviano PN 33081 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Amman 11941 Jordan Details
Novartis Investigative Site Seongnam Si Gyeonggi Do 13620 Korea, Republic of Details
Novartis Investigative Site Dora 90375 Lebanon Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Mexico City 06760 Mexico Details
Novartis Investigative Site Matosinhos 4454 513 Portugal Details
Novartis Investigative Site Porto 4100-180 Portugal Details
Novartis Investigative Site Cluj-Napoca 400124 Romania Details
Novartis Investigative Site Golnik 4204 Slovenia Details
Novartis Investigative Site Ljubljana 1000 Slovenia Details
Novartis Investigative Site Cordoba Andalucia 14004 Spain Details
Novartis Investigative Site Oviedo Asturias 33011 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Alicante Comunidad Valenciana 03010 Spain Details
Novartis Investigative Site Pamplona Navarra 31008 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Tainan 70403 Taiwan Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Ankara Yenimahalle 06200 Turkey Details
Novartis Investigative Site Adana 01140 Turkey Details
Novartis Investigative Site Ankara 06500 Turkey Details
Novartis Investigative Site Ankara 06560 Turkey Details
Novartis Investigative Site Ankara 06680 Turkey Details
Novartis Investigative Site Cankaya Ankara 06560 Turkey Details
Novartis Investigative Site Fatih-Istanbul 34093 Turkey Details
Novartis Investigative Site Fatih 34093 Turkey Details
Novartis Investigative Site Istanbul 34662 Turkey Details
Novartis Investigative Site Istanbul 34890 Turkey Details
Novartis Investigative Site Pendik Istanbul 34899 Turkey Details
Novartis Investigative Site Hanoi 300000 Vietnam Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field